What is Lexeo Therapeutics, Inc. Common Stock's Market Cap?

Lexeo Therapeutics, Inc. Common Stock's Market Cap is $367.6M, based on as-reported figures from SEC (XBRL) filings.

What is Lexeo Therapeutics, Inc. Common Stock's Enterprise Value?

Lexeo Therapeutics, Inc. Common Stock's Enterprise Value is $275.3M, based on as-reported figures from SEC (XBRL) filings.

What is Lexeo Therapeutics, Inc. Common Stock's EV / EBITDA?

Lexeo Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Lexeo Therapeutics, Inc. Common Stock's Net Income (TTM)?

Lexeo Therapeutics, Inc. Common Stock's Net Income (TTM) is -$87.3M, based on as-reported figures from SEC (XBRL) filings.

What is Lexeo Therapeutics, Inc. Common Stock's EBITDA?

Lexeo Therapeutics, Inc. Common Stock's EBITDA is -$94.8M, based on as-reported figures from SEC (XBRL) filings.

What is Lexeo Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Lexeo Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.06, based on as-reported figures from SEC (XBRL) filings.

What is Lexeo Therapeutics, Inc. Common Stock's Net Debt?

Lexeo Therapeutics, Inc. Common Stock's Net Debt is -$92.3M, based on as-reported figures from SEC (XBRL) filings.

Lexeo Therapeutics, Inc. Common Stock (LXEO) Financial Statements

Lexeo Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00YB1C8N4

XNAS · usd

4.48▼ 0.28 (-5.88%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close4.76

Day's Range4.48 – 4.81

52-Week Range3.99 – 10.99

Volume311.6K

Avg Volume779.7K

Share Statistics

Shares Outstanding

Employees59

ExchangeXNAS

Listed2023-11-03

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Lexeo Therapeutics, Inc. Common Stock (LXEO)

What is Lexeo Therapeutics, Inc. Common Stock's Market Cap?: Lexeo Therapeutics, Inc. Common Stock's Market Cap is $367.6M, based on as-reported figures from SEC (XBRL) filings.
What is Lexeo Therapeutics, Inc. Common Stock's Enterprise Value?: Lexeo Therapeutics, Inc. Common Stock's Enterprise Value is $275.3M, based on as-reported figures from SEC (XBRL) filings.
What is Lexeo Therapeutics, Inc. Common Stock's EV / EBITDA?: Lexeo Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Lexeo Therapeutics, Inc. Common Stock's Net Income (TTM)?: Lexeo Therapeutics, Inc. Common Stock's Net Income (TTM) is -$87.3M, based on as-reported figures from SEC (XBRL) filings.
What is Lexeo Therapeutics, Inc. Common Stock's EBITDA?: Lexeo Therapeutics, Inc. Common Stock's EBITDA is -$94.8M, based on as-reported figures from SEC (XBRL) filings.
What is Lexeo Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Lexeo Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.06, based on as-reported figures from SEC (XBRL) filings.
What is Lexeo Therapeutics, Inc. Common Stock's Net Debt?: Lexeo Therapeutics, Inc. Common Stock's Net Debt is -$92.3M, based on as-reported figures from SEC (XBRL) filings.